Protagonist Therapeutics, Inc Increase (Decrease) in Accounts Payable, Trade
Protagonist Therapeutics, Inc (PTGX) reported Increase (Decrease) in Accounts Payable, Trade of -$1.90 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsPayableTrade · last filed 2026-08-05
- Protagonist Therapeutics, Inc increase (decrease) in accounts payable, trade for the quarter ending 2026-06-30 was -$4.90M, a 1406.67% decline year-over-year.
- Protagonist Therapeutics, Inc increase (decrease) in accounts payable, trade for the quarter ending 2026-03-31 was $3.00M, a 142.76% increase year-over-year.
- Protagonist Therapeutics, Inc increase (decrease) in accounts payable, trade for the quarter ending 2025-12-31 was -$307.00K.
- Protagonist Therapeutics, Inc increase (decrease) in accounts payable, trade for the quarter ending 2025-09-30 was $2.42M.
- Protagonist Therapeutics, Inc increase (decrease) in accounts payable, trade for fiscal 2025 was $3.72M, a 342.16% increase from fiscal 2024.
- Protagonist Therapeutics, Inc increase (decrease) in accounts payable, trade for fiscal 2024 was $842.00K.
- Protagonist Therapeutics, Inc increase (decrease) in accounts payable, trade for fiscal 2023 was -$2.87M, a 240.24% decline from fiscal 2022.
- Protagonist Therapeutics, Inc increase (decrease) in accounts payable, trade for fiscal 2022 was $2.04M.
| Period end | Increase (Decrease) in Accounts Payable, Trade 3 month | Increase (Decrease) in Accounts Payable, Trade 6 month | Increase (Decrease) in Accounts Payable, Trade 9 month | Increase (Decrease) in Accounts Payable, Trade 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$4.90M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | -$1.90M 10-Q · filed 2026-08-05 | -$2.20M derived: sum of 3 quarters · filed 2026-08-05 | $214.00K derived: sum of 4 quarters · filed 2026-08-05 |
| 2026-03-31 | $3.00M 10-Q · filed 2026-05-05 | $2.70M derived: sum of 2 quarters · filed 2026-05-05 | $5.11M derived: sum of 3 quarters · filed 2026-05-05 | $5.49M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-12-31 | -$307.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $2.11M derived: sum of 2 quarters · filed 2026-02-25 | $2.49M derived: sum of 3 quarters · filed 2026-08-05 | $3.72M 10-K · filed 2026-02-25 |
| 2025-09-30 | $2.42M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $2.79M derived: sum of 2 quarters · filed 2026-08-05 | $4.03M 10-Q · filed 2025-11-06 | $2.60M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-06-30 | $375.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $1.61M 10-Q · filed 2026-08-05 | $182.00K derived: sum of 3 quarters · filed 2026-08-05 | -$173.00K derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-03-31 | $1.24M 10-Q · filed 2026-05-05 | -$193.00K derived: sum of 2 quarters · filed 2026-05-05 | -$548.00K derived: sum of 3 quarters · filed 2026-05-05 | -$746.00K derived: sum of 4 quarters · filed 2026-05-05 |
| 2024-12-31 | -$1.43M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | -$1.78M derived: sum of 2 quarters · filed 2026-02-25 | -$1.98M derived: sum of 3 quarters · filed 2026-02-25 | $842.00K 10-K · filed 2026-02-25 |
| 2024-09-30 | -$355.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | -$553.00K derived: sum of 2 quarters · filed 2025-11-06 | $2.27M 10-Q · filed 2025-11-06 | $1.68M derived: sum of 4 quarters · filed 2026-02-25 |
| 2024-06-30 | -$198.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-06 | $2.63M 10-Q · filed 2025-08-06 | $2.03M derived: sum of 3 quarters · filed 2026-02-25 | -$1.17M derived: sum of 4 quarters · filed 2026-02-25 |
| 2024-03-31 | $2.83M 10-Q · filed 2025-05-06 | $2.23M derived: sum of 2 quarters · filed 2026-02-25 | -$976.00K derived: sum of 3 quarters · filed 2026-02-25 | -$424.00K derived: sum of 4 quarters · filed 2026-02-25 |
| 2023-12-31 | -$597.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | -$3.80M derived: sum of 2 quarters · filed 2026-02-25 | -$3.25M derived: sum of 3 quarters · filed 2026-02-25 | -$2.87M 10-K · filed 2026-02-25 |
| 2023-09-30 | -$3.20M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | -$2.65M derived: sum of 2 quarters · filed 2024-11-07 | -$2.27M 10-Q · filed 2024-11-07 | -$3.35M derived: sum of 4 quarters · filed 2025-02-21 |
| 2023-06-30 | $552.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-06 | $933.00K 10-Q · filed 2024-08-06 | -$143.00K derived: sum of 3 quarters · filed 2025-02-21 | $3.16M derived: sum of 4 quarters · filed 2025-02-21 |
| 2023-03-31 | $381.00K 10-Q · filed 2024-05-07 | -$695.00K derived: sum of 2 quarters · filed 2025-02-21 | $2.61M derived: sum of 3 quarters · filed 2025-02-21 | -$3.13M derived: sum of 4 quarters · filed 2025-02-21 |
| 2022-12-31 | -$1.08M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-21 | $2.23M derived: sum of 2 quarters · filed 2025-02-21 | -$3.51M derived: sum of 3 quarters · filed 2025-02-21 | $2.04M 10-K · filed 2025-02-21 |
| 2022-09-30 | $3.31M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-02 | -$2.44M derived: sum of 2 quarters · filed 2023-11-02 | $3.12M 10-Q · filed 2023-11-02 | $4.02M derived: sum of 4 quarters · filed 2024-02-27 |
| 2022-06-30 | -$5.74M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03 | -$184.00K 10-Q · filed 2023-08-03 | $711.00K derived: sum of 3 quarters · filed 2024-02-27 | -$6.45M derived: sum of 4 quarters · filed 2024-02-27 |
| 2022-03-31 | $5.56M 10-Q · filed 2023-05-04 | $6.45M derived: sum of 2 quarters · filed 2024-02-27 | -$705.00K derived: sum of 3 quarters · filed 2024-02-27 | $4.51M derived: sum of 4 quarters · filed 2024-02-27 |
| 2021-12-31 | $895.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-27 | -$6.26M derived: sum of 2 quarters · filed 2024-02-27 | -$1.05M derived: sum of 3 quarters · filed 2024-02-27 | -$1.39M 10-K · filed 2024-02-27 |
| 2021-09-30 | -$7.16M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | -$1.94M derived: sum of 2 quarters · filed 2022-11-08 | -$2.29M 10-Q · filed 2022-11-08 | -$2.01M derived: sum of 4 quarters · filed 2023-03-15 |
| 2021-06-30 | $5.22M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | $4.87M 10-Q · filed 2022-08-04 | $5.15M derived: sum of 3 quarters · filed 2023-03-15 | $5.11M derived: sum of 4 quarters · filed 2023-03-15 |
| 2021-03-31 | -$344.00K 10-Q · filed 2022-05-05 | -$67.00K derived: sum of 2 quarters · filed 2023-03-15 | -$108.00K derived: sum of 3 quarters · filed 2023-03-15 | -$948.00K derived: sum of 4 quarters · filed 2023-03-15 |
| 2020-12-31 | $277.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-15 | $236.00K derived: sum of 2 quarters · filed 2023-03-15 | -$604.00K derived: sum of 3 quarters · filed 2023-03-15 | $309.00K 10-K · filed 2023-03-15 |
| 2020-09-30 | -$41.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-03 | -$881.00K derived: sum of 2 quarters · filed 2021-11-03 | $32.00K 10-Q · filed 2021-11-03 | $1.20M derived: sum of 4 quarters · filed 2022-02-28 |
| 2020-06-30 | -$840.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-04 | $73.00K 10-Q · filed 2021-08-04 | $1.24M derived: sum of 3 quarters · filed 2022-02-28 | $71.00K derived: sum of 4 quarters · filed 2022-02-28 |
| 2020-03-31 | $913.00K 10-Q · filed 2021-05-04 | $2.08M derived: sum of 2 quarters · filed 2022-02-28 | $911.00K derived: sum of 3 quarters · filed 2022-02-28 | -$2.78M derived: sum of 4 quarters · filed 2022-02-28 |
| 2019-12-31 | $1.17M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28 | -$2.00K derived: sum of 2 quarters · filed 2022-02-28 | -$3.70M derived: sum of 3 quarters · filed 2022-02-28 | -$3.00M 10-K · filed 2022-02-28 |
| 2019-09-30 | -$1.17M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-04 | -$4.86M derived: sum of 2 quarters · filed 2020-11-04 | -$4.17M 10-Q · filed 2020-11-04 | -$3.35M derived: sum of 4 quarters · filed 2021-03-10 |
| 2019-06-30 | -$3.69M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06 | -$3.00M 10-Q · filed 2020-08-06 | -$2.19M derived: sum of 3 quarters · filed 2021-03-10 | $418.00K derived: sum of 4 quarters · filed 2021-03-10 |
| 2019-03-31 | $696.00K 10-Q · filed 2020-05-07 | $1.51M derived: sum of 2 quarters · filed 2021-03-10 | $4.11M derived: sum of 3 quarters · filed 2021-03-10 | |
| 2018-12-31 | $813.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-10 | $3.42M derived: sum of 2 quarters · filed 2021-03-10 | $4.43M 10-K · filed 2021-03-10 | |
| 2018-09-30 | $2.60M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-06 | $3.62M 10-Q · filed 2019-11-06 | ||
| 2018-06-30 | $1.01M 10-Q · filed 2019-08-07 | |||
| 2017-12-31 | $91.00K 10-K · filed 2020-03-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 | |
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | United States | $6.771B | -37.20 |